In Stock
Beclomin 250 HFA
Tk321
- Stock: In Stock
- Brand: Square Pharmaceuticals
- Product ID: Beclomethasone Dipropionate 250 mcg Inhalation Solution
0 Pcs sold
5500 Interested
100% Secure Payment
This Item is for pre order
Estimated Delivery in
Tags:
beclomin
, 250
, hfa
, beclomethasone
, dipropionate
, 250
, mcg
, inhalation
, solution
, beclomethasone
, dipropionate
Indication:
Beclometasone 100 & 250 HFA Inhaler is indicated in the prophylactic management of mild, moderate, or severe asthma in adults or children.
Beclometasone dipropionate given by inhalation offers preventative treatment for asthma. It provides effective anti-inflammatory action in the lungs with a
lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.
Mild asthma :
Patients requiring symptomatic bronchodilator asthma medication on a regular basis.
Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy
or
bronchodilator alone.
Severe asthma : Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms. Many patients who are dependent on systemic corticosteroids for adequate control of symptoms may be able to reduce significantly, or eliminate, their requirement for oral corticosteroids when they are transferred to high dose inhaled beclometasone dipropionate.
Beclometasone dipropionate given by inhalation offers preventative treatment for asthma. It provides effective anti-inflammatory action in the lungs with a
lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.
Mild asthma :
Patients requiring symptomatic bronchodilator asthma medication on a regular basis.
Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy
or
bronchodilator alone.
Severe asthma : Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms. Many patients who are dependent on systemic corticosteroids for adequate control of symptoms may be able to reduce significantly, or eliminate, their requirement for oral corticosteroids when they are transferred to high dose inhaled beclometasone dipropionate.
%20Pvt.%20Ltd./Movicol-Oral-Powder-190x190.jpg "Movicol Oral Powder")
